RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets

Oncogene

Volumn 32, Issue 20, 2013, Pages 2576-2585

  Kent, O A ^a   Fox Talbot, K ^a   Halushka, M K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal; KRAS; miR 143; miR 145; miRNA; RREB1

Indexed keywords

BINDING PROTEIN; K RAS PROTEIN; MICRORNA 143; MICRORNA 145; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; RAS RESPONSIVE ELEMENT BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL STRAIN HCT116; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; HETEROZYGOSITY LOSS; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ADENOCARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; PROMOTER REGIONS, GENETIC; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84878018679     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.266     Document Type: Article

References (57)

1. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355. (Pubitemid 39265675)
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
3. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133: 217-222. (Pubitemid 351508308)
4. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752. (Pubitemid 46856245)
5. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134. (Pubitemid 47014436)
6. Barbacid M. Ras genes. Annu Rev Biochem 1987; 56: 779-827.
7. Hingorani SR, Tuveson DA. Ras redux: rethinking how and where Ras acts. Curr Opin Genet Dev 2003; 13: 6-13. (Pubitemid 36143921)
8. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647. (Pubitemid 40343076)
9. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010; 18: 282-293.
10. Kent OA, Chivukula RR, Mullendore M, Wentzel EA, Feldmann G, Lee KH et al. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev 2010; 24: 2754-2759.
11. Date S, Nibu Y, Yanai K, Hirata J, Yagami K, Fukamizu A. Finb, a multiple zinc finger protein, represses transcription of the human angiotensinogen gene. Int J Mol Med 2004; 13: 637-642.
12. Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J et al. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol 2007; 21: 2056-2070. (Pubitemid 47347373)
13. Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, Diamond L et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996; 16: 5335-5345. (Pubitemid 26315052)
14. Thiagalingam A, Lengauer C, Baylin SB, Nelkin BD. RREB1, a ras responsive element binding protein, maps to human chromosome 6p25. Genomics 1997; 45: 630-632. (Pubitemid 27506141)
15. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, van Uitert M et al. Largescale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 2008; 133: 727-741. (Pubitemid 351637624)
16. Zhang S, Qian X, Redman C, Bliskovski V, Ramsay ES, Lowy DR et al. p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 2003; 22: 2285-2295. (Pubitemid 36566784)
17. Zhang L, Zhao J, Edenberg HJ. A human Raf-responsive zinc-finger protein that binds to divergent sequences. Nucleic Acids Res 1999; 27: 2947-2956. (Pubitemid 29335717)
18. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385-1392.
19. Michael MZ, O'Connor SM, van Holst PNG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-891. (Pubitemid 37288707)
20. Akao Y, Nakagawa Y, Naoe T. MicroRNAs 143 and 145 are possible common oncomicroRNAs in human cancers. Oncol Rep 2006; 16: 845-850.
21. Kressner U, Glimelius B, Bergström R, Påhlman L, Larsson A, Lindmark G. Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer. Br J Cancer 1998; 11: 1848-1851. (Pubitemid 28254622)
22. Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH, Pachen MM et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 2003; 24: 703-710. (Pubitemid 36592405)
23. Calcagno SR, Li S, Colon M, Kreinest PA, Thompson EA, Fields AP et al. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int J Cancer 2008; 122: 2462-2470. (Pubitemid 351590478)
24. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397-402. (Pubitemid 351238155)
25. Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristama ̈ki R et al. MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 2012; 51: 1-9.
26. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6. (Pubitemid 38391943)
27. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 2007; 8: R131.
28. Gaspar C, Cardoso J, Franken P, Molenaar L, Morreau H, Möslein G et al. Crossspecies comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am J Pathol 2008; 172: 1363-1380. (Pubitemid 351671549)
29. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H et al. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007; 5: 1263-1275.
30. Zhu H, Dougherty U, Robinson V, Mustafi R, Pekow J, Kupfer S et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western dietpromoted murine colon cancer: role of G1 regulators. Mol Cancer Res 2011; 9: 960-975.
31. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
32. Nitz MD, Harding MA, Smith SC, Thomas S, Theodorescu D. RREB1 transcription factor splice variants in urologic cancer. Am J Pathol 2011; 179: 477-486.
33. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993; 260: 85-88. (Pubitemid 23122749)
34. Keller JW, Haigis KM, Franklin JL, Whitehead RH, Jacks T, Coffey RJ. Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS: gelsolin complex. Oncogene 2007; 26: 3051-3059. (Pubitemid 46733639)
35. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANAmirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009; 25: 1991-1993.
36. Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, Bergemann TL et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009; 323: 1747-1750.
37. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
38. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006; 5: 29.
39. Barker N, Ridgway RA, van Es JH, van de Wetering H, Begthel H, van den Born M et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-611.
40. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009; 101: 699-706.
41. Borralho PM, Simões AE, Gomes SE, Lima RT, Carvalho T, Ferreira DM et al. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One 2011; 6: e23787.
42. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009; 106: 3207-3212.
43. Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y et al. Mutational and nonmutational activation of p21ras in rat colonic azoxymethaneinduced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res 2000; 60: 4602-4609. (Pubitemid 32103646)
44. Buzzi N, Colicheo A, Boland R, de Boland AR. MAP kinases in proliferating human colon cancer Caco-2 cells. Mol Cell Biochem 2009; 328: 201-208.
45. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279: 52361-52365. (Pubitemid 39656612)
46. Clape C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F et al. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 2009; 4: e7542.
47. Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 2009; 276: 6689-6700.
48. Han SX, Zhu Q, Ma JL, Zhao J, Huang C, Jia X et al. Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2. World J Gastroenterol 2010; 16: 4541-4548.
49. Liu AW, Cai J, Zhao XL, Jiang TH, He TF, Fu HQ et al. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth. Clin Cancer Res 2011; 17: 710-720.
50. Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ, Liu C et al. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. J Pathol 2010; 220: 475-489.
51. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-1037. (Pubitemid 24106383)
52. Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P et al. Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol 2011; 31: 1565-1576.
53. Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B et al. JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J 2009; 28: 1843-1854.
54. Adler V, Qu Y, Smith SJ, Izotova L, Pestka S, Kung HF et al. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway. Biochemistry 2005; 44: 10784-10795. (Pubitemid 41153639)
55. Feldmann G, Habbe N, Dhara S, Bisht S, Alvarez H, Fendrich V et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 2008; 57: 1420-1430.
56. Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V, Der CJ. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res 2007; 67: 2098-2106. (Pubitemid 46424228)
57. Kent OA, Mullendore M, Wentzel EA, Lopez-Romero P, Tan AC, Alvarez H et al. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol Ther 2009; 8: 2013-2024.